(Q34257603)

31 July 2017

Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview (English)

1 reference

polycystic ovary syndrome

31 July 2017

1 reference

1 reference

1 reference

1 reference

Ghina S Ghazeeri

1

1 reference

31 July 2017

Anwar H Nassar

series ordinal

2

1 reference

31 July 2017

Zeina Younes

series ordinal

3

1 reference

31 July 2017

Johnny T Awwad

series ordinal

4

1 reference

31 July 2017

1 May 2012

1 reference

Acta Obstetricia et Gynecologica Scandinavica

31 July 2017

1 reference

31 July 2017

91

1 reference

31 July 2017

6

1 reference

31 July 2017

658-678

1 reference

A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome

31 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Metformin for the treatment of the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Comparative effects of atorvastatin and simvastatin on the plasma total homocysteine levels in women with polycystic ovary syndrome: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Diagnosis, phenotype, and prevalence of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Does PCOS have developmental origins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Pregnancy outcome in women with PCOS and in controls matched by age and weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Pregnancy complications in PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Prevalence of gestational diabetes mellitus and pregnancy outcomes in Asian women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Metformin administration improves endothelial function in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Metformin has no major effects on glucose homeostasis in pregnant women with PCOS: results of a randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughou

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Effects of metformin on early pregnancy loss in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Evaluation of the relationship between gestational diabetes and a history of polycystic ovarian syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Obstetric outcome in women with polycystic ovarian syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Endocrino-metabolic features in women with polycystic ovary syndrome during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Impaired glucose tolerance in pregnant women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Assessment of glucose tolerance and pregnancy outcome of polycystic ovary patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Sex hormone-binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Continuation of metformin in the first trimester of women with polycystic ovarian syndrome is not associated with increased perinatal morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2012.01385.X

10.1111/J.1600-0412.2012.01385.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference